A mouse study from WashU Medicine suggests a new approach to preventing brain cell death from certain neurological diseases.

Study finds that near-daily cannabis users had more seizures and needed specialized care sooner than nonusers.

Researchers find changes during anti-amyloid treatment that may indicate treatment response and inform clinical decision-making.

The findings of a WashU Medicine study could help pave the way for earlier intervention against necrotizing enterocolitis.

A WashU Medicine clinical trial supports adding mental health coaching and medication cleanup to routine pre-surgical care.

WashU Medicine researchers reduced Alzheimer’s-like neurodegeneration in mice by preventing immune cells from traveling to the brain.

The first reported robotic double transplant of a liver and kidney was performed by WashU Medicine surgeons operating in the Barnes-Jewish Transplant Center.

The blood-based biomarker test is based on technology developed at WashU Medicine by Randall Bateman, MD, and David Holtzman, MD.

The discovery may offer a new way to fight brain cancer and neurodegenerative disease, WashU Medicine researchers report.

A large analysis of patient outcomes shows that the extent of tumor ablation and timing of treatment extend survival.

Findings from a mouse study by WashU Medicine researchers could lead to targeted treatments for chronic nerve pain.

A professor medicine and of genetics at WashU Medicine, Timothy Ley led the team that sequenced the first cancer genome.

A new study identifies brain differences tied to sensory distress in children, which is often linked to anxiety and autism.

A mouse study finds changes to DNA packaging form a molecular memory of trauma, making the brain vulnerable to future stress.

Researchers have developed a way to generate a type of cellular protein with unpredictable forms that have until now eluded systematic study.

A family-based behavioral intervention helped nearly half of kids in a clinical trial reach a healthier weight.

WashU Medicine researchers have shown in mice that administering anti-cancer drugs in modular form improves treatment effectiveness

Cases of dementia climbed in Mexico, Peru and Puerto Rico over two decades, bucking a downward trend seen in many wealthy nations.

Founding members of the consortium include WashU Medicine, pharmaceutical companies, philanthropic groups and others.

A mouse study finds inflammatory microbes in mothers that affect fetal growth and the intestinal health of offspring.

An earbud-like device from WashU startup Aurenar is designed to improve stroke outcomes after a ruptured brain aneurysm.

Faster aging in younger generations is linked to the rise in early-onset cancers, according to a new analysis.

The discovery could lead to a single vaccine against E. coli, Shigella and other causes of severe diarrhea.

A new study finds the shot, currently in FDA review, could offer broader and longer-lasting protection compared to the standard flu shot.

Sleep, screen time and stress — but not IQ — are also linked to children’s brain features.

A cutting-edge procedure for treating sickle cell disease is changing lives in the St. Louis area, where an estimated 1,200 people have the debilitating blood disorder.

Study finds that programs that analyze eye images could also speed up drug trials

Bioengineered parasites could serve as long-term drug factories inside human gut, a new study from WashU Medicine researchers shows.

A blood test developed by the founders of C2N Diagnostics was the first of its kind to measure a key marker of Alzheimer's disease in patients.

One organ donor can save up to eight lives and improve the lives of more than 75 people through eye and tissue donation. More than 100,000 people are currently on the national transplant waiting list,...

Wellness and longevity influencers are pushing a compound called NAD+. There's scientific interest in its potential, but researchers say the marketing claims have gotten ahead of the science.

WashU will confer seven honorary degrees during its 165th Commencement May 15. Here are the recipients.

An engineered CAR-T cell strategy seeks to expand immunotherapies for highly aggressive types of leukemia and other blood cancers.

A WashU Medicine-led clinical trial has found that a personalized vaccine to treat glioblastoma appears to increase recurrence-free survival in a subset of patients after surgery.

WashU Medicine researchers have discovered a novel cellular process that protects against liver disease caused by toxic protein buildup.

The drug is for a small subset of patients. But evidence that breathing and strength can get better for some of them is remarkable for a paralyzing, usually fatal disease.

WashU Medicine research on gut microbiome is part of movement to reshape NICU preemie care